Longitudinal persistence of negative symptoms in young individuals with first episode schizophrenia: a 24-month multi-modal program follow-up

References

• Galderisi S, Mucci A, Buchanan RW, et al. Negative symptoms of schizophrenia: new developments and unanswered research questions. Lancet Psychiatry. 2018;5(8):664–677.
   PubMed Web of Science ®Google Scholar
• Ucok A, Ergul C. Persistent negative symptoms after first episode schizophrenia: a 2-year follow-up study. Schizophr Res. 2014;158:241–246.
   PubMed Web of Science ®Google Scholar
• Yung AR, Nelson B, McGorry PD, et al. Persistent negative symptoms in individuals at ultra high risk for psychosis. Schizophr Res. 2019;206:355–361.
   PubMed Web of Science ®Google Scholar
• Devoe DJ, Lu L, Cannon TD, et al. Persistent negative symptoms in youth at clinical high risk for psychosis: a longitudinal study. Schizophr Res. 2021;227:28–37.
   PubMed Web of Science ®Google Scholar
• Poletti M, Pelizza L, Azzali S, et al. Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project. Eur Child Adolesc Psychiatry. 2019;28(7):957–971.
   PubMed Web of Science ®Google Scholar
• Ang MS, Rekhi G, Lee J. Validation of the brief negative symptom scale and its association with functioning. Schizophr Res. 2019;208:97–104.
   PubMed Web of Science ®Google Scholar
• Buchanan RW. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull. 2007;33(4):1013–1022.
   PubMed Web of Science ®Google Scholar
• Bucci P, Mucci A, van Rossum IW, et al. Persistent negative symptoms in recent-onset psychosis: relationship to treatment response and psychosocial functioning. Eur Neuropsychopharmacol. 2020;34:76–86.
   PubMed Web of Science ®Google Scholar
• Chue P, Lalonde JK. Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options. Neuropsychiatr Dis Treat. 2014;10:777–779.
   PubMed Web of Science ®Google Scholar
• Galderisi S, Mucci A, Dollfus S, et al. EPA guidance on assessment of negative symptoms in schizophrenia. Eur Psychiatry. 2020;18:1–91.
   Google Scholar
• Fusar-Poli P, Papanastasiou E, Stahl D, et al. Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials. Schizophr Bull. 2015;41(4):892–899.
   PubMed Web of Science ®Google Scholar
• Bucci P, Galderisi S. Categorizing and assessing negative symptoms. Curr Opin Psychiatry. 2017;30(3):201–208.
   PubMed Web of Science ®Google Scholar
• Cerveri G, Gesi C, Mencacci C. Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm. Neuropsychiatr Dis Treat. 2019;15:1525–1535.
   PubMed Web of Science ®Google Scholar
• Hovington CL, Bodnar M, Chakravarty MM, et al. Investigation of white matter abnormalities in first episode psychosis patients with persistent negative symptoms. Psychiatry Res. 2015;233(3):402–408.
   PubMed Web of Science ®Google Scholar
• Bodnar M, Hovington CL, Buchy L, et al. Cortical thinning in temporo-parietal junction (TPJ) in non-affective first-episode psychosis patients with persistent negative symptoms. PLoS One. 2014;9(6):e101372.
   PubMed Web of Science ®Google Scholar
• Correll CU, Schooler NR. Negative symptoms in schizophrenia: a review and clinical guide for recognition, assessment, and treatment. Neuropsychiatr Dis Treat. 2020;16:519–534.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276.
   PubMed Web of Science ®Google Scholar
• Mucci A, Merlotti E, Ucok A, et al. Primary and persistent negative symptoms: concepts, assessments and neurobiological bases. Schizophr Res. 2017;186:19–28.
   PubMed Web of Science ®Google Scholar
• Leuci E, Quattrone E, Pellegrini P, et al. The “Parma-Early psychosis” program: general description and process analysis after 5 years of clinical activity. Early Interv Psychiatry. 2020;14(3):356–364.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. IV edition, text revision (DSM-IV-TR). Washington DC: APA Press; 2000.
   Google Scholar
• Woods SW, Yung AR, McGorry PD, et al. Duration of untreated psychosis: getting both the timing and the sample right. Am J Psychiatry. 2020;177(12):1183.
   PubMed Web of Science ®Google Scholar
• Poletti M, Pelizza L, Azzali S, et al. Overcoming the gap between child and adult mental health services: the reggio emilia experience in an early intervention in psychosis program. Early Interv Psychiatry. 2021;15(6):1749–1758.
   PubMed Web of Science ®Google Scholar
• Wechsler D. WAIS-IV: Wechsler Adult Intelligence Scale. Fourth Edition. Firenze: Giunti; 2013.
   Google Scholar
• Wechsler DW. IV: Wechsler Intelligence Scale for children. Fourth Edition. Firenze: Giunti; 2012.
   Google Scholar
• Yung AR, Yuen YP, McGorry PD, et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry. 2005;39(11–12):964–971.
   PubMed Web of Science ®Google Scholar
• Landi G, Leuci E, Quattrone E, et al. The “‘Parma-early psychosis' programme: characterization of help-seekers with first episode psychosis.” Early Interv Psychiatry. 2021;15(2):380–390.
   PubMed Web of Science ®Google Scholar
• Shafer A, Dazzi F. Meta-analysis of the positive and negative syndrome scale (PANSS) factor structure. J Psychiatr Res. 2019;115:113–120.
   PubMed Web of Science ®Google Scholar
• Tonna M, Ossola P, Marchesi C, GET UP Group, et al. Dimensional structure of first episode psychosis. Early Interv Psychiatry. 2019;13(6):1431–1438.
   PubMed Web of Science ®Google Scholar
• Pelizza L, Azzali S, Paterlini F, et al. Negative symptom dimensions in first episode psychosis: is there a difference between schizophrenia and non-schizophrenia spectrum disorders? Early Interv Psychiatry. 2021;15(6):1513–1521.
   PubMed Web of Science ®Google Scholar
• Lasalvia A, Bonetto C, Lenzi J, GET UP Group, et al. Predictors and moderators of treatment outcome in patients receiving multi-element psychosocial intervention for early psychosis: results from the GET uP pragmatic cluster randomised controlled trial. Br J Psychiatry. 2017;210(5):342–349.
   PubMed Web of Science ®Google Scholar
• Pelizza L, Landi G, Pellegrini C, et al. Negative symptom configuration in first episode schizophrenia: findings from the “‘Parma Early Psychosis’ program”. Nord J Psychiatry. 2020;74(4):251–258.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV-TR axis I disorders (SCID-I). New York, NY: New York State Psychiatric Institute, 2002.
   Google Scholar
• Makowski C, Bodnar M, Shenker JJ, et al. Linking persistent negative symptoms to amygdala-hippocampus structure in first-episode psychosis. Transl Psychiatry. 2017;7(8):e1195–e1195.
   PubMedGoogle Scholar
• National Institute for health and Care Excellence (NICE). Psychosis and schizophrenia in children and young people: recognition and management. London: NICE Press, 2016.
   Google Scholar
• Barnes TR, Drake R, Paton C, et al. Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2020;34(1):3–78.
   PubMed Web of Science ®Google Scholar
• Fowler D, Garety P, Kuipers E. Cognitive behavior therapy for psychosis. Leicester: Wiley & Sons; 1995.
   Google Scholar
• Kuipers E, Leff J, Lam D. Family work for schizophrenia: a practical guide. London: Gaskell; 2002.
   Google Scholar
• Leuci E, Pelizza L, Landi G, et al. Personal health budget in patients with first episode psychosis: a new rehabilitation model based on a community care system in Italy. Early Interv Psychiatry. 2021; doi:10.1111/eip/13145.
   Web of Science ®Google Scholar
• Pelizza L, Leuci E, Landi G, et al. Personal health budget as a new rehabilitation model for severe mental illness within a caring community: an Italian evaluation study of beneficial effects. Aust N Z J Psychiatry. 2021;55(6):602–612.
   PubMed Web of Science ®Google Scholar
• SPSS Inc. Statistical package for social science (SPSS) for windows, version 15.0. Chicagi, IL: SPSS Inc. Press, 2010.
   Google Scholar
• Ver Hoef JM. Who invented the Delta method? Am Stat. 2012;66(2):124–127.
   Web of Science ®Google Scholar
• Pelizza L, Azzali S, Paterlini F, et al. Characterization of young people with first episode psychosis or at ultra-high risk: the Reggio Emilia at-risk mental states (ReARMS) program. Riv Psichiatr. 2019;54(6):254–263.
   PubMed Web of Science ®Google Scholar
• Preti A, Meneghelli A, Pisano A, Programma 2000 Team, et al. Risk of suicide and suicidal ideation in psychosis: results from an Italian multi-modal pilot program on early intervention in psychosis. Schizophr Res. 2009;113(2–3):145–150.
   PubMed Web of Science ®Google Scholar
• Belvedere Murri M, Bertelli R, Carozza P, et al. First-episode psychosis in the Ferrara mental health department: incidence and clinical course within the first 2 years. Early Interv Psychiatry. 2021;15(6):1738–1748.
   PubMed Web of Science ®Google Scholar
• Kirkbride JB, Errazuriz A, Croudace TJ, et al. Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One. 2012;7(3):e31660.
   PubMed Web of Science ®Google Scholar
• Hovington CL, Bodnar M, Joober R, et al. Identifying persistent negative symptoms in first episode psychosis. BMC Psychiatry. 2012;12:224.
   PubMed Web of Science ®Google Scholar
• Puig O, Baeza I, de la Serna E, the PEPs Group, et al. Persistent negative symptoms in first-episode psychosis: early cognitive and social functioning correlates and differences between early and adult onset. J Clin Psychiatry. 2017;78(9):1414–1422.
   PubMed Web of Science ®Google Scholar
• Pelizza L, Maestri D, Leuci E, et al. Negative symptom configuration within and outside schizophrenia spectrum disorders: results from the “‘Parma Early Psychosis’ program”. Psychiatry Res. 2020;294:113519.
   PubMed Web of Science ®Google Scholar
• Ince E, Ucok A. Relationship between persistent negative symptoms and findings of neurocognition and neuroimaging in schizophrenia. Clin EEG Neurosci. 2018;49:27–35.
   PubMed Web of Science ®Google Scholar
• Chang WC, Hui CL, Tang JY, et al. Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study. Schizophr Res. 2011;133(1–3):22–28.
   PubMed Web of Science ®Google Scholar
• Galderisi S, Mucci A, Bitter I, Eufest Study Group, et al. Persistent negative symptoms in first episode patients with schizophrenia: results from the European first episode schizophrenia trial. Eur Neuropsychopharmacol. 2013;23(3):196–204.
   PubMed Web of Science ®Google Scholar
• Lutgens D, Gariepy G, Malla A. Psychological and psychosocial interventions for negative symptoms in psychosis: systematic review and Meta-analysis. Br J Psychiatry. 2017;210(5):324–332.
   PubMed Web of Science ®Google Scholar
• Priebe S, Savill M, Wykes T, et al. Effectiveness of group body psychotherapy for negative symptoms of schizophrenia: multicentre randomised controlled trial. Br J Psychiatry. 2016;209(1):54–61.
   PubMed Web of Science ®Google Scholar
• Favrod J, Nguyen A, Chaix J, et al. Improving pleasure and motivation in schizophrenia: a randomized controlled clinical trial. Psychother Psychosom. 2019;88(2):84–95.
   PubMed Web of Science ®Google Scholar
• Dieterich M, Irving CB, Bergman H, et al. Intensive case management for severe mental illness. Cochrane Database Syst Rev. 2017;1:CD007906.
   PubMedGoogle Scholar
• Burns T, Catty J, Dash M, et al. Use of intensive case management to reduce time in hospital in people with severe mental illness: systematic review and meta-regression. BMJ. 2007;335(7615):336–340.
   PubMedGoogle Scholar
• Poletti M, Azzali S, Paterlini F, et al. Familiarity for serious mental illness in help-seeking adolescents at clinical high risk of psychosis. Front Psychiatry. 2020;11(552282):552282.
   PubMedGoogle Scholar
• Kirkpatrick B, Strauss GP, Nguyen L, et al. The brief negative symptom scale: psychometric properties. Schizophr Bull. 2011;37(2):300–305.
   PubMed Web of Science ®Google Scholar